| Literature DB >> 28388601 |
Robert A Darnall1,2, Xi Chen3, Krishnamurthy V Nemani3, Chrystelle M Sirieix1, Barjor Gimi3, Susan Knoblach4, Betty L McEntire5, Carl E Hunt4,6.
Abstract
BackgroundPreterm infants are frequently exposed to intermittent hypoxia (IH) associated with apnea and periodic breathing that may result in inflammation and brain injury that later manifests as cognitive and executive function deficits. We used a rodent model to determine whether early postnatal exposure to IH would result in inflammation and brain injury.MethodsRat pups were exposed to IH from P2 to P12. Control animals were exposed to room air. Cytokines were analyzed in plasma and brain tissue at P13 and P18. At P20-P22, diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS) were performed.ResultsPups exposed to IH had increased plasma Gro/CXCL1 and cerebellar IFN-γ and IL-1β at P13, and brainstem enolase at P18. DTI showed a decrease in FA and AD in the corpus callosum (CC) and cingulate gyrus, and an increase in RD in the CC. MRS revealed decreases in NAA/Cho, Cr, Tau/Cr, and Gly/Cr; increases in TCho and GPC in the brainstem; and decreases in NAA/Cho in the hippocampus.ConclusionsWe conclude that early postnatal exposure to IH, similar in magnitude to that experienced in human preterm infants, is associated with evidence for proinflammatory changes, decreases in white matter integrity, and metabolic changes consistent with hypoxia.Entities:
Mesh:
Year: 2017 PMID: 28388601 PMCID: PMC5509485 DOI: 10.1038/pr.2017.102
Source DB: PubMed Journal: Pediatr Res ISSN: 0031-3998 Impact factor: 3.756
Figure 1a. Pattern of intermittent hypoxia. There are 6 decreases to ~ 6% per hour alternating with an hour of normoxia, 24 hours/day, 7 days/week. Each decrease lasts ~ 3 minutes resulting in 72 hypoxia events per day. b. Decreases in chamber oxygen concentration (CHO2), oxyhemoglobin saturation (SaO2) and associated increases in heart rate (HR) with each decrease. c. Timeline for the intermittent hypoxia (IH) exposure, biomarkers of acute injury and DTI/MRS protocols.
Figure 3a. Regions of Interest (ROI) for DTI studies shown in several coronal planes. Corpus Callosum (CC) (green); Cingulate Gyrus (CG) (orange); Fimbria (F) (yellow); Internal Capsule (IC) (red). b. Example FA maps for an IH and RA control pup. Note in particular the decrease in density of the CC (corpus callosum) (white arrows) and CG (cingulate gyrus) (red arrows)
Metabolites, lipids, and macromolecules quantified using TARQUIN
| Alanine, Aspartate, Citrate, Creatine (Cr), γ-aminobutyric acid (GABA), Glucose (Glc), Glutamine, Glutamate, Glutathione, Glycerophosphocholine (GPC), Glycine (Gly), m-Inositol, Lactate, N-acetylaspartate (NAA), N-acetylaspartyl glutamate (NAAG), Phosphoethanolamine (Choline, Cho), Phosphocholine (pCho), Phosphocreatine (pCr), Scyllo-Inositol, Taurine (Tau) | Lipid 09, Lipid 13a, Lipid 13b, Lipid 20 |
Figure 2Inflammatory biomarker results at P13 in rat pups exposed to IH at P2–P12, compared to normoxic controls. a. Plasma concentrations of GRO/CXCL1 (pg/ml) b. Cerebellar concentrations of cerebellar IFN-γ and IL-1β (pg/ml).
Figure 4Changes in FA, AD, RD and MD for the regions of interest (CC=corpus callosum; CG=cingulate gyrus; F=fimbria; IC=internal capsule; AVG=average across all regions. Gray symbols represent pups exposed to IH. Open symbols are room air-exposed control pups. Blue lines indicate the medians. Significant values are shown in bold underline (P<0.05). Non-significant changes with P≤0.08 are shown in grey.
Figure 5An example TARQUIN model spectrum from the hippocampus in a P22 control rat pup. The X-axis shows the chemical shift for each peak. Peaks for Creatine (Cr), Choline (Cho), Taurine (Tau), and N-acetyl Aspartate (NAA) are shown. The inset shows the region of interest including the left hippocampus.
Metabolite concentration changes that were significant or had P values of ≤ 0.08 following exposure to intermittent hypoxia
| Metabolite | Brainstem | Hippocampus | ||||||
|---|---|---|---|---|---|---|---|---|
| RA | IH | P | RA | IH | P | |||
| ↓ | 4.12 ± 1.29 | 4.00 ± 1.72 | 0.880 | |||||
| 2.63 ± 1.39 | 3.40 ± 0.95 | 0.220 | 4.55 ± 1.50 | 4.68 ± 1.17 | 0.870 | |||
| ↑ | 8.67 ± 1.76 | 8.67 ± 1.30 | 1.00 | |||||
| ↓ | ↓ | |||||||
| 2.40 ± 1.45 | 1.43 ± 0.39 | 0.080 | ↓ | 1.94 ± 0.49 | 1.46 ± 0.47 | 0.080 | ↓ | |
| 1.59 ± 1.39 | 0.71 ± 0.27 | 0.080 | ↓ | 0.45 ± 0.23 | 0.42 ± 0.62 | 0.910 | ||
| 3.99 ± 2.61 | 2.14 ± 0.57 | 0.060 | ↓ | 2.40 ± 0.60 | 1.88 ± 0.42 | 0.070 | ||
| 4.07 ± 1.30 | 5.20 ± 0.91 | 0.070 | ↑ | 5.90 ± 1.87 | 7.29 ± 1.99 | 0.190 | ||
| ↑ | 1.47 ± 0.42 | 1.12 ± 0.25 | 0.090 | |||||
| 0.35 ± 0.20 | 0.59 ± 0.24 | 0.060 | ↑ | 0.64 ± 0.33 | 0.59 ± 0.25 | 0.740 | ||
| ↑ | 0.83 ± 0.22 | 0.53 ± 0.39 | 0.080 | ↓ | ||||
| ↓ | 2.55 ± 1.17 | 2.54 ± 0.64 | 0.980 | |||||
| 3.94 ± 0.54 | 3.87 ± 1.36 | 0.900 | ↑ | |||||
| ↓ | 0.56 ± 0.45 | 0.79 ± 0.38 | 0.290 | |||||
| 2.53 ± 1.71 | 1.28 ± 0.69 | 0.070 | ↓ | 1.37 ± 0.65 | 1.22 ± 0.37 | 0.580 | ||
| 0.72 ± 0.76 | 0.20 ± 0.25 | 0.070 | ↓ | 0.20 ± 0.24 | 0.23 ± 0.18 | 0.760 | ||
| 3.47 ± 2.87 | 1.71 ± 0.67 | 0.080 | ↓ | 1.02 ± 0.59 | 0.92 ± 0.33 | 0.700 | ||
Cr (creatine), p (phosphoryl), T (total), NAA (N-acetylaspartate), Cho (choline), GPC (glycerophosphocholine), Tau (taurine), Gly (glycine), GABA (λ-aminobutyric acid), Ins (inositol). Arrows indicate direction of change. Significant values are bolded. Values are mM.